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Association of an IL-1A 3UTR polymorphism with end-stage The likelihood of developing end-stage renal disease
renal disease and IL-1 expression. (ESRD) has increased approximately 50% among all
Background. We evaluated polymorphisms in the interleu- racial groups from 1990 to 1998 [1]. ESRD, characterizedkin-1 alpha 3-untranslated region (IL-1A 3[UTR]) for associ-
by underlying glomerulosclerosis and fibrosis, is a leadingation with type 2 diabetes–associated (DM) and nondiabetic-
cause of morbidity and mortality among individuals withassociated (non-DM) end-stage renal disease (ESRD) in two
ethnic groups. diabetes, hypertension, and glomerulonephritis [1]. While
Methods. IL-1A 3UTR polymorphisms were identified by Mendelian forms of renal disease exist, ESRD more typi-
alignment of overlapping human expressed sequence tags (ESTs). cally demonstrates a heterogeneous etiology resulting fromSequence ambiguities were experimentally confirmed and vari-
a complex interaction of both genetic and environmentalants genotyped to test for association with ESRD in 75 unre-
factors. There are significant race-specific differences inlated Caucasians with DM ESRD, 95 unrelated Caucasian con-
trols and, in a parallel study, 92 unrelated African Americans risk of developing ESRD with African Americans being
with type 2 DM ESRD, 95 unrelated African Americans with at 4.5-, 2.79-, and 2.25-fold higher risk than Caucasians,
non-DM ESRD, and 86 unrelated African American controls.
Asians, or Native Americans, respectively [1]. Familial clus-IL-1A 3 UTR genotype and lipopolysaccharide (LPS)-stimu-
tering of ESRD with its associated co-morbid conditionslated IL-1 protein levels were measured in healthy Caucasians
(N  112) and African Americans (N  101) to evaluate suggests that genetic factors are key in its development.
association between genotype and protein level. Normal kidney function is dependent on a tightly regu-
Results. A polymorphism in the 3 UTR of the human IL-1A lated process of synthesis and degradation of extracellu-
gene was associated with ESRD and IL-1 protein expression.
lar matrix (ECM) proteins. Neutral proteases known asThe polymorphism consists of two single nucleotide polymor-
matrix metalloproteinases (MMPs) and their inhibitorsphisms (SNPs) and an insertion/deletion generating four differ-
ent haplotypes: TN7TTCAA, AN7TTCAA, TN7TTCAG and are essential in maintaining the normal ECM turnover of
an allele deleted for four internal bases, TN7(delTTCA)A. The connective tissue surrounding mesangial cells. Evidence
4 bp deletion allele, TN7(delTTCA)A, was significantly less supporting an inflammatory component in the develop-common among Caucasian DM ESRD and African American
ment of nephropathy, characterized by glomerular base-non-DM ESRD patients (recessive model; P  0.0364 and P 
ment membrane thickening and mesangial expansion ex-0.0293, respectively). In vitro, this polymorphism is associated
with the amount of IL-1 protein synthesized in LPS-stimu- ists [2]. Specifically, changes in the expression of MMP-9
lated lymphocytes from healthy subjects (P  0.0013, additive lead to dysregulation of normal ECM turnover [3]. In-
model), with the TN7(delTTCA)A haplotype associated with flammatory mediators such as interleukin-1 (IL-1),higher levels of stimulated IL-1.
tumor necrosis factor- (TNF-) and nitric oxide synthe-Conclusion. The association of the TN7(delTTCA)A haplo-
type with higher levels of IL-1 expression and reduced risk tase (NOS) affect the expression of MMP-9 in rat mesan-
for ESRD is consistent with involvement of cytokines in risk gial cells [4]. In humans, polymorphisms in IL-1B and
for developing nephropathy. interleukin-1 receptor antagonist (IL-1RN), genes resid-
ing in the IL-1 gene cluster, are associated with diabetic
nephropathy [5–7]. Familial clustering and evidence sup-
porting an inflammatory component in the developmentKey words: interleukin-1 alpha, 3-untranslated region, end-stage renal
disease, association, interleukin-1 alpha protein level. of nephropathy suggest inflammatory mediators as can-
didate genes for ESRD susceptibility.Received for publication July 3, 2002
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and IL-1RN, that are expressed in both physiologic and samples consisted of 95 healthy individuals as controls
and 75 ESRD patients with a diagnosis of type 2 DM.pathologic conditions. The IL-1 cytokines are regulated
at many levels and play a key role in the host’s response African American samples consisted of 86 healthy em-
ployees at North Carolina Baptist Hospital (Winston-to microbial infection, as well as ECM turnover and bone
resorption. At the cellular level, both membrane-bound Salem, NC) as controls, 92 samples from ESRD patients
with a diagnosis of type 2 DM, and 95 samples fromreceptors, soluble receptors, decoy receptors, IL-1Ra and
natural anti-IL-1 antibodies, exist to maintain the balance ESRD patients with a diagnosis of non-DM–associated
renal failure (primarily chronic glomerular disease, hyper-between pro- and anti-inflammatory responses within the
cell. IL-1A and IL-1B, the two best characterized IL-1 tension, or unknown etiologies of ESRD). Due to the
high frequency of diabetes among first-degree relativesagonists, demonstrate consistent interindividual differ-
ences in protein production rates in response to stimula- of probands with non-DM–related ESRD reported by
Bergman et al [25], we carefully screened our non-DM–tion [8, 9]. These “high” and “low” producer phenotypes
have a molecular basis, and in some instances are associ- associated ESRD participants to eliminate those with
diabetes. Recruitment and clinical characteristics of ourated with inflammatory and autoimmune conditions.
Specifically, within IL-1A, a genetic association exists patients with ESRD have been previously described [6].
Subjects and samples for IL-1 expression studies. Thebetween a promoter polymorphism and juvenile rheuma-
toid arthritis and early-onset Alzheimer’s disease [10, 11]. study population consisted of 112 healthy, unrelated
Caucasians and 101 healthy, unrelated African Ameri-A second IL-1A variation within intron 6, a 46 bp tandem
repeat (VNTR), influences gene expression [12]. In addi- cans born in North Carolina ascertained from an ongoing
study of the genetics of type 2 DM. Uncoagulated bloodtion, IL-1A and IL-1B genotypes are significantly associ-
ated with the severity of periodontal disease, while an (30 to 45 mL) was obtained by venipuncture for IL-1
expression analysis and genotyping.IL-1RN polymorphism contributes to the susceptibility
to severe sepsis [13, 14]. The association of IL-1 gene
DNA preparationcluster polymorphisms with inflammatory diseases and
the link between IL-1 and MMP in renal matrix mainte- Total genomic DNA was purified from peripheral blood
leukocytes using PUREGENEDNA isolation kit (Gene-nance has made these genes attractive candidates for
evaluation in patients with ESRD. tra, Minneapolis, MN, USA). Quantification of DNA was
determined using standardized fluorimetric readings onWhile investigations of several variants of IL-1B and
IL-1RN have identified regulatory polymorphisms asso- a Hoefer DyNA Quant 200 fluorimeter (Hoefer Phar-
macia Biotech Inc., San Francisco, CA, USA).ciated with chronic renal failure and diabetic nephropa-
thy in Caucasians and African Americans, little is known
Identification of 3-UTR polymorphismsabout the impact of variations in IL-1A [5–7]. Although
several polymorphisms within regulatory regions of IL-1A The complete IL-1A coding sequence (accession no.
M28983) was used as the query in a BLAST search of theexist, little focus has been placed on the identification
of variants within the 3 untranslated region and their po- GenBank human expressed sequence tags (EST) data-
base, masking repeats. Twenty-seven BLAST hits withtential effect on the development of ESRD [11, 12]. Reg-
ulatory elements within the 3 untranslated region affect- expect values less that 6E-06 were identified and aligned
using fragment assembly software (FAS) (Fragment As-ing mRNA stability and translational efficiency have
been described in a number of cytokine genes including sembly Software; Wisconsin Package GCG Version 10,
Accelrys, San Diego, CA, USA) [26] to the genomicIL-1A, and are characterized by multiple AUUUA or
AUUUUA motif repeats, termed AU-rich elements DNA sequence (accession no. X03833). Twenty-one ESTs
formed a single contiguous DNA sequence spanning 1354(AREs) [15–20]. Here, we describe the identification of
a polymorphic sequence in the 3UTR of the IL-1A gene, nt (X03833 nt10290.. 11643) corresponding to exon 7.
Evaluation of the alignment revealed 10 possible SNPthe association of this polymorphism with ESRD, and a
functional analysis of alleles of this polymorphism on sites of which four of the candidate SNP alleles were
represented in more than one EST. Primers flankingIL-1A gene expression.
the region containing these four sites were designed to
amplify a 182 bp product (X03833 nt11309..11490) for
METHODS
detailed analysis.
Subjects
Single-strand conformational polymorphism (SSCP)ESRD patients and controls. Association studies were
and DNA sequence analysisconducted in five distinct samples of unrelated individu-
als. ESRD patients’ DNA samples were from our ongo- Oligonucleotide primers (IL-1A 3UTR forward, 5-CTT
GGGAGACCTGTAATCAT-3 and IL-1A 3UTR re-ing studies of diabetes (DM)-associated and nondiabetes
(non-DM)-associated renal failure [6, 21–24]. Caucasian verse, 5-GTGGTCTCATGGTTGTCAA-3) designed
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to amplify the 182 bp region containing candidate SNPs IL-1 expression
were end-labeled with [-32P] deoxyadenosine triphos- Heparinized blood was divided into two 900 L ali-
phate (dATP) (4500 Ci/mmol, 2.2mol/L; ICN Biomedi- quots and placed in 1.5 mL Eppendorf tubes. One 900
cals, Inc., Costa Mesa, CA, USA) in a 37.5 L reaction L aliquot remained unstimulated, while 1g/mL Esche-
[105 pmol oligonucleotide primer, 100 mmol/L Tris-HCl richia coli 0111:B4 lipopolysaccharide (LPS) (Sigma
(pH 7.6 at 25C), 10 mmol/L MgCl2, 5 mmol/L dithiothrei- Chemical Co., St. Louis, MO, USA) at 100 ng/mL final
tol (DTT), and 7.5 U T4 polynucleotide kinase; Promega, concentration was added to the other aliquot. Both sam-
Madison, WI, USA] at 37C for 30 minutes, followed by ples were placed at 37C in 5% CO2 overnight (20 to 24
heat inactivation at 70C for 10 minutes. Polymerase hours). Following incubation an equal volume of cell-
chain reaction (PCR) amplification for SSCP analysis lysis buffer was added to the entire cell suspension and
was performed using 60 ng genomic DNA in a 10 L plasma was separated by centrifugation for 5 minutes at
reaction [50 mmol/L KCl, 100 mmol/L Tris-HCl pH 8.8, 1500g and frozen at20C until enzyme-linked immuno-
1.2 mmol/L MgCl2, 0.2 mmol/L each deoxynucleoside sorbent assay (ELISA) analysis. IL-1 protein was quan-
triphosphate (dNTP), 4 pmol each unlabeled oligonucle- titated by ELISA (Immunotech, Westerbrook, ME, USA).
otide, 0.9 pmol each end-labeled oligonucleotide, 8 nmol This assay detects IL-1 protein levels with a sensitivity
spermidine, and 1.0 unit of Taq polymerase]. The PCR of approximately 5 to 15 pg/mL depending on the length
mixture was denatured for 5 minutes at 94C, then cycled of incubation with substrate.
for 35 cycles (30 seconds at 94C, 30 seconds at 58C,
Statistical analysisand 30 seconds at 72C), and a final extension at 72C
for 7 minutes. The PCR products were then diluted 1:8 Genotype with disease. Allele frequencies were tested
with loading dye (95% formamide, 10 mmol/L NaOH, for departures from Hardy-Weinberg proportions using
0.25% bromophenol blue, and 0.25% xylene cyanol), a likelihood ratio test. To test for an association between
denatured at 95C for 2 minutes and placed immediately the insertion/deletion (I/D) polymorphism and ESRD,
on ice. Heat-denatured products (1.6 L) were then sep- contingency table analyses [27] were computed using
arated by electrophoresis on polyacrylamide gels con- SAS. Within the Caucasian sample, the controls were
taining 0.5 	 mutation detection enhancement (MDE) compared to DM ESRD cases for an overall genotypic
acrylamide (FMC BioProducts, Rockland, ME, USA), association, and under dominant (homozygous insertion
0.6 X TBE, and 5% glycerol at room temperature for vs. the combined homozygous and heterozygous dele-
17 hours at 11 watts. Gels were exposed to x-ray film tion) and recessive (homozygous deletion vs. homozy-
(Kodak, Rochester, NY, USA) for 18 to 24 hours. gous and heterozygous insertion) genetic models using
DNA samples displaying variant banding patterns in a likelihood ratio chi-square test; the corresponding addi-
SSCP were prepared for sequencing using 100 ng of human tive genetic model was tested using the integer-based
genomic DNA in a reaction volume of 60 L containing trend test [27]. An identical set of tests were computed
10 mmol/L Tris-HCl pH 8.2, 50 mmol/L KCl, 1.5 mmol/L within the African American sample contrasting the
MgCl2, 0.2 mM each of dATP, deoxyeytidine triphosphate three groups (i.e., controls vs. DM ESRD vs. non-DM
(dCTP), deoxyguanosine triphosphate (dGTP), and deox- ESRD). A secondary analysis compared controls with
thymidine triphosphate (dTTP), 24 pmol forward and DM ESRD and controls with non-DM ESRD. To test
reverse primer and 1.5 units of Taq polymerase. PCR whether any association between controls and DM
cycling conditions were identical to those used in SSCP- ESRD differed by ethnic groups, a Breslow-Day test for
PCR described above. PCR products were separated on homogeneity of the odds ratio was computed [28].
a 1% agarose gel containing ethidium bromide (220 Genotype with protein level. To test for an association
g/L) in a 1 	 TAE buffer [40 mmol/L Tris-acetate, 1 between the I/D polymorphism and IL-1 levels, a series
mmol/L ethylediaminetetraacetic acid (EDTA) pH 8.0] of analysis of covariance models were computed. The
and visualized on an ultraviolet transilluminator. The hypotheses tested by these models parallel that of the case/
appropriate 182 bp DNA product was gel extracted using control analyses described above. Specifically, within each
QIAquick gel extraction kit (Qiagen, Inc., Valencia, CA, ethnic group the overall genotypic association with IL-1
USA) following the manufacturer’s recommendations. levels, and the three a priori contrasts corresponding to
Approximately 50 to 150 ng of purified DNA from each the three genetic models (i.e., recessive, additive, and
sample and 3.6 pmol of the appropriate oligonucleotide dominant) were computed. Standard regression diagnos-
primer were submitted to the Wake Forest University tics were computed to insure that the data approximate
Baptist Medical Center DNA Sequencing Core Facility the appropriate distributional assumptions of the analy-
for fluorescent sequencing using an ABI Prism 377 auto- sis of covariance model. Although the tests for the un-
mated sequencer (Applied Biosystems, Inc., Foster City, stimulated, stimulated, and change in IL-1 levels are
provided, only the latter two are of primary interest.CA, USA).
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Table 1. NCBI expressed sequence tags (ESTs) used in fragment bp region (Fig. 2). The 4 bp I/D polymorphism is 260
assembly of IL-1A 3UTR
bp 3 to the last AU-rich element.
NCBI EST Accession No.
Association analysis of the 3UTR deletionAA749413 AA856674 AI026629
AA916672 AA831119 AI632261 polymorphism with ESRD
AI968736 AA832199 AI655493
The IL-1A 3UTR polymorphisms were genotyped inAW294546 AA970954 AI654996
AA936768 AA922689 AW268673 a collection of DNA samples from patients and controls
AA916823 AW341637 AA856671 to evaluate association with ESRD. The patient samples
AI954814 AI655512 AI022317
consisted of genomic DNAs from 75 Caucasians with
DM ESRD, 95 unrelated healthy Caucasians (control
group), 92 African Americans with DM ESRD, 95 Afri-
can Americans with non-DM ESRD, and 86 unrelated
In order to protect the type I error rate in both sets
healthy African Americans (control group). Table 2 sum-
of analyses, statistical significance at the   0.05 level
marizes the results of the genotyping. The frequency of
for the genotypic association test was required before the four different haplotypes, p, q, r, and s (defined in
inferring significance of the individual genetic models; Fig. 1) as determined by genotyping are summarized in
this approach is consistent with the Fisher’s protected Table 2 for each of the five populations evaluated in the
least significant difference approach to multiple compari- study. As related above, the r and s haplotypes were not
sons [29]. observed in Caucasians and therefore not considered in
this analysis, reducing the polymorphism to a simple I/D
based on the presence or absence of the TTCA sequence.RESULTS
The p haplotype is most common in each of the fiveIdentification of polymorphisms in the 3UTR of the
populations. The frequency of the q haplotype appearsIL-1A gene
to be reduced in ESRD cases compared to controls in
ESTs sharing sequence identity to the 3UTR of IL-1A both African Americans and Caucasians. There was no
were identified through BLAST searches of the National evidence that the within ethnic group allele frequencies
Center for Biotechnology Information (NCBI) human departed from Hardy-Weinberg proportions.
EST database (Table 1). Alignment of these EST se- The positive association of the IL-1A 3UTR polymor-
quences identified a region of ambiguity consisting of phism with ESRD was evaluated using tests for an overall
several putative sequence variants. SSCP analysis was genotypic association and the three a priori genetic mod-
used to screen 10 DNA samples from each of five case- els. Among African Americans, all four haplotypes, p,
control populations (Table 2). Seven different patterns q, r, and s were observed. The two SNPs flanking the 4 bp
were observed in the SSCP survey. The greatest variabil- I/D site were of low frequency and for this reason the
ity was observed in patterns from the African American four haplotypes were grouped into one of two haplo-
DNA samples. Through sequence analysis of genomic types: with the 4 bp insertion or the 4 bp deletion haplo-
DNAs with different SSCP patterns, we found that the type. The genotypes in the five populations and results
multiple patterns are due to different combinations of four of the association analysis are summarized in Table 3.
haplotypes (named p, q, r, and s) (Fig. 1) corresponding There was no evidence of a strong overall association
to combinations of two different SNPs: T/A at 11409 and between genotype and DM ESRD in either the Caucasian
A/G at 11423 in the reference IL-1A gene sequence (P  0.1208) or African American sample (P  0.4002);
(GenBank X03833) with the I/D of a 4 bp sequence albeit, there was a modest association under both the
TTCA beginning at 11419 (Fig. 1). The 11409 and 11423 additive and recessive genetic models (P  0.0634 and
SNPs are uncommon and observed only in African P  0.0364, respectively) in the Caucasian sample.
Americans. These SNPs were not evaluated for their An additional sample group of African American non-
association as the low allele frequencies significantly re- DM ESRD patients was available for association analy-
duced our power to detect differences. As a conse- sis. In this case, there was a strong genotypic association
quence, the 4 bp I/D polymorphism is the major contribu- with ESRD in the non-DM sample (P  0.0069). When
tor to sequence variation. The 4 bp I/D polymorphism specific models of inheritance were applied, and controls
is listed as rs16347 in the NCBI dbSNP databases on were compared with non-DM ESRD, all genetic models
the reverse strand, but neither flanking SNP had been were significant with the additive model exhibiting the
cataloged. The sequence variants are within a 15 bp strongest evidence of association (P  0.0073). A com-
region contained in the 182 bp amplimer in exon 7 that parison of controls vs. DM ESRD vs. non-DM ESRD
comprises part of the IL-1A 3UTR (Fig. 2). Sequence (2 	 3 contingency table analysis) also revealed an asso-
analysis of the primary transcript identified 6 AU consen- ciation (P  0.0243). When the three samples were
jointly analyzed with specific models of inheritance, thesus sequences (AUUUA or AUUUUA) across the 1153
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Table 2. Haplotype frequencies among five case-control groups
Study Population
Caucasian Caucasian type 2 African American African American African American
Haplotype and controls DM ESRD controls type 2 DM ESRD Non-DM ESRD
Frequency (N  190)a (N  150)a (N  172)a (N  184)a (N  190)a
p (
4 bp) 127 66.8% 106 70.3% 103 59.9% 111 60.3% 128 67.4%
q (4 bp) 63 33.2% 44 29.3% 51 29.7% 45 24.5% 33 17.4%
r (
4 bp) — — 18 10.5% 27 14.7% 28 14.7%
s (
4 bp) — — — 2 1.1% 2 1.1%
p, r, s (
4 bp) 127 66.8% 106 70.3% 121 70.3% 139 75.5% 153 80.5%
Abbreviations are: DM ESRD, diabetes-associated end-stage renal disease; non-DM, nonassociated diabetes end-stage renal disease.
a N represents the number of chromosomes
Fig. 1. Genotypes corresponding to the seven
single-strand conformational polymorphism
(SSCP) patterns observed. Haplotypes con-
firmed by DNA sequencing.
additive (P  0.0314) and the recessive (P  0.0293) assay batch (Table 4). The highest level of protein was
observed in homozygotes for the deletion allele. No sig-models exhibited the strongest evidence of association.
nificant association was seen between unstimulated IL-
Association of IL-1 levels with IL-1A the 3UTR 1 levels and genotype in either ethnic group (P  0.15,
polymorphism Table 4). As the number of deletion alleles increased so
did the amount of LPS-stimulated IL-1 expression inWith evidence of association of the IL-1A 3UTR
polymorphism and ESRD, the functional impact of this both ethnic groups (P  0.0037).
Adjusting for ethnicity and assay batch, the change inpolymorphism was examined. IL-1 gene expression was
measured as a function of genotype in a collection of IL-1 level was associated with the I/D polymorphism
in the test for an overall genotypic association and allhealthy controls (112 Caucasian and 101 African Ameri-
can individuals). Blood samples were obtained for DNA three modes of inheritance (Table 4). This association
appears to be strongest under an additive genetic modeland IL-1 protein analysis. Levels of IL-1 were mea-
sured in both unstimulated- and LPS-stimulated whole (P  0.0013), although there is not sufficient statistical
power to rule out other modes of inheritance. There wasblood obtained from each study subject. IL-1 levels [un-
stimulated, stimulated, and the corresponding differ- no evidence of an ethnicity by genotype interaction (P 
0.1413). Unadjusted for ethnicity or assay batch, the pro-ence (change  stimulated minus unstimulated)] were
compared across genotypes adjusting for ethnicity and portion of the variation in the change in IL-1 level
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Fig. 2. Interleukin-1 alpha (IL-1A) gene (ac-
cession no. X03833) structure and 3 untrans-
lated region (UTR) AU-rich sequence contain-
ing polymorphisms. The two SNPs (positions
11409 and 11423), one 4 nt insertion/deletion
(I/D) (position 11419..11422) polymorphism
and the 6 AU-rich elements (AREs) within
the genomic DNA sequence are indicated by
bold type and underline. Genomic sequence
is truncated at 11643 to correspond with the
end of the primary transcript.
Table 3. Genotype frequencies with general- and model-specific association analyses by ethnic group
Genotypes
P value
Genetic models
General
Sample groups pp pq qq pr qra rr ps association Dominant Additive Recessive
Caucasians
Controls (N  95) 42 43 10 —c —c —c —c
Type 2 DM ESRD (N  75) 33 40 2 —c —c —c —c 0.1208 0.9781 0.0634 0.0364
African Americans
Controls (N  86) 31 33 7 8 4 3 —c
Type 2 DM ESRD (N  92) 34 23 7 19 8 —c 1 0.4002 0.187 0.727 0.8954
African Americans
Controlsa (N  86) 31 33 7 8 4 3 —c
Non-type 2 DM ESRD (N  95) 42 25 1 19 5 2 1 0.0069 0.0113 0.0073 0.015
Type 2 DM ESRD vs. Non-type 2 DM ESRDb 0.0243 0.0404 0.0314 0.0293
Abbreviations are: type 2 DM ESRD, type 2 diabetes-associated end-stage renal disease; non-type 2 DM ESRD, non-type 2 diabetes-associated end-stage renal
disease.
aSame control group as type 2 DM ESRD comparison above
bP value corresponds to statistical significance of 2 	 3 contigency table. No Caucasian non-type 2 DM ESRD comparison group available.
cNo individuals with the haplotype pair
explained by the I/D polymorphism was approximately DISCUSSION
6% (R2  0.06). The importance of local production of cytokines, ei-
Individuals heterozygous for the deletion variant pro- ther by the glomeruli or infiltrating inflammatory cells,
duced approximately 13% more IL-1 in response to in the pathogenesis of glomerular disease has been sug-
LPS stimulation than individuals without the deletion. gested for more than 10 years [30, 31]. Currently, angio-
Estimates of the level of increase in homozygotes for tensin-converting enzyme (ACE) inhibitors are utilized
the deletion allele were between 28% to 45% in African to slow the progression of renal failure, but may not be
Americans and Caucasians, respectively; these estimates able to prevent the development of ESRD [32]. Anti-
should be viewed with caution given the relatively small cytokine strategies are being evaluated in animal models
number of homozygote-deletion genotypes in both sam- of progressive renal disease, including experimentally
induced diabetes in rats and mice with lupus nephritis [32].ples (three African Americans and 11 Caucasians).
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While renoprotective effects have been demonstrated by
some of these compounds, the immunogenic nature of
these peptides may prohibit their use in humans [33]. No
preventive therapies exist for ESRD and, consequently,
investigators continue to evaluate various cytokines as
potential targets for prevention of renal failure. Primary
mediators of inflammation, including interleukins, are
candidates for the pathogenesis of ESRD. We identified
haplotypes consisting of SNPs and a 4 bp I/D polymor-
phism in the 3UTR of IL-1A (Fig. 2) and evaluated
these polymorphisms for their association with ESRD
in Caucasians and Africans Americans. The haplotype
with the 4 bp deletion allele has a reduced frequency in
patients with renal disease (Table 2), and this reduction
was significantly associated in Caucasian and African
Americans with type 2 DM ESRD, and strongly associ-
ated in African Americans with non-DM ESRD (Table 3).
Our initial focus in this study was to evaluate the African
American population because of the well-documented
strong familial aggregation of ESRD in this racial group
[34, 35]. From these results, it is clear that an analysis
of non-DM ESRD in Caucasians is warranted to see if
the IL-1A 3UTR polymorphisms also contribute risk to
this group. It is important to note, however, that the
relative risk for ESRD in Caucasians is four- to fivefold
lower than for African Americans, and consequently, a
much larger sample group may be needed to see an
equivalent effect [36, 37]. Depending upon the race, dis-
ease association of ESRD (e.g., DM or non-DM), and
genetic model, an association between the I/D polymor-
phism and ESRD was apparent in these data. The model
(e.g., recessive or additive) that most accurately describes
this association is, however, unclear at this time. Compara-
ble evaluations in additional, large data sets may help to
more clearly define the genetic basis of this association.
Functional analysis of IL-1A 3UTR 4 nt I/D shows
that the presence of the deletion allele is associated with
increased LPS-stimulated IL-1 expression (Table 5).
The mechanism by which the IL-1A 3-UTR I/D poly-
morphism affects ESRD susceptibility remains to be eluci-
dated but the IL-1A 3UTR 4 nt deletion polymorphism
is located 250 nt distal to a region rich in AUUUA-like
sequences (Fig. 1). AUUUA-like sequences affect tran-
script stability and RNA protein binding [16–20, 38–40].
AREs are present in a number of cytokine genes, includ-
ing IL-2, IL-6, IL-8, and TNF- [16–20]. Posttranscrip-
tional stabilization of labile transcripts are regulated by
ARE binding proteins for a wide variety of genes, includ-
ing multiple cytokine genes [15, 41–44]. Since 3UTR vari-
ations regulating at the posttranscriptional or transla-
tional level are associated with traits such as obesity
[45], it is attractive to speculate that the 3UTR variants
somehow participate in posttranscriptional or transla-
tional regulation.
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